A Phase I, Open-Label Study to Characterise the Absorption, Distribution, Metabolism and Excretion Following a Single Oral Dose of [14C]AZD5069 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2015
At a glance
- Drugs AZD 5069 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 06 Jul 2011 Actual end date Jul 2011 added as reported by ClinicalTrials.gov record.
- 06 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jun 2011 Actual initiation date (May 2011) , Additional location [England] added as reported by ClinicalTrials.gov.